Immunological response to mistletoe (Viscum album L.) in cancer patients: A four-case series

Phytotherapy Research

Volumn 23, Issue 3, 2009, Pages 407-411

  Gardin, Nilo Esvalter ^a  

^a NONE   (Brazil)

Author keywords

Cancer; Lectins; Loranthaceae; Mistletoe; Viscotoxins; Viscum album

Indexed keywords

ANTINEOPLASTIC AGENT; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VISCUM ALBUM EXTRACT;

ADULT; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CASE REPORT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; DELAYED HYPERSENSITIVITY; DRUG MECHANISM; DRUG TOLERABILITY; FEMALE; HODGKIN DISEASE; HUMAN; HUMORAL IMMUNITY; INJECTION SITE ERYTHEMA; INJECTION SITE INDURATION; INJECTION SITE PAIN; INTRACUTANEOUS TEST; LEUKOCYTE COUNT; MALE; MULTIPLE MYELOMA; PRURITUS; VISCUM ALBUM;

ADOLESCENT; ANTIBODY FORMATION; FEMALE; HUMANS; IMMUNITY, CELLULAR; IMMUNOLOGIC FACTORS; INJECTIONS, SUBCUTANEOUS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; NEOPLASMS; PLANT EXTRACTS; VISCUM ALBUM;

LORANTHACEAE; VISCUM; VISCUM ALBUM;

EID: 61449189674     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2643     Document Type: Article

References (31)

1. Becker H. 1986. Botany of European Mistletoe (Viscum album L.). Oncology 43 (Suppl. 1): 2-7.
2. Bloksma N, Schmiermann P, de Reuver M, van Dijk H, Willers J. 1982. Stimulation of humoral and cellular immunity by Viscum preparations. Planta Med 46: 221-227.
3. Boon T, Coulie PG, Bruggen P, Baren N. 2000. Immunologic basis of cancer. In Abeloff: Clinical Oncology, 2nd edn. Churchill Livingstone: Orlando; 158-241.
4. Bussing A, Bischof M, Hatzmann W et al. 2005. Prevention of surgery-induced suppression of granulocyte function by intravenous application of a fermented extract from Viscum album L. in breast cancer patients. Anticancer Res 25(6C): 4753-4757.
5. Chernyshov VP, Heusser P, Omelchenko LI et al. 2000. Immunomodulatory and clinical effects of Viscum album (Iscador M and Iscador P) in children with recurrent respiratory infections as a result of the Chernobyl nuclear accident. Am J Ther 7: 195-203.
6. Coulon A, Mosbah A, Lopez A et al. 2003. Comparative membrane interaction study of viscotoxins A3, A2 and B from mistletoe (Viscum album) and connections with their structures. Biochem J 374: 71-78.
7. Ernst E, Schmidt K, Steuer-Vogt MK. 2003. Mistletoe for cancer? A systematic review of randomised clinical trials. Int J Cancer 107: 262-267.
8. Franz H. 1986. Request for an impartial discussion of the so-called mistletoe therapy. Oncology 43 (Suppl. 1): 1.
9. Frantz M, Jung ML, Ribereau-Gayon G, Anton R. 2000. Modulation of mistletoe (Viscum album L.) lectins cytotoxicity by carbohydrates and serum lycoproteins. Arzneimittelforschung 50:471-478.
10. Gorter RW, van Wely M, Reif M, Stoss M. 1999. Tolerability of an extract of European mistletoe among immunocom-promised and healthy individuals. Altern Ther Health Med 5: 37-44.
11. Grossarth-Maticek R, Kiene H, Baumgartner SM, Ziegler R. 2001. Use of Iscador, an extract of European mistletoe (Viscum album), in cancer treatment: prospective nonrandomized and randomized matched-pair studies nested within a cohort study. Altern Ther Health Med 7: 57-66, 68-72, 74-76 passim.
12. Hajto T. 1986. Immunomodulatory effects of iscador: a Viscum album preparation. Oncology 43 (Suppl. 1): 51-65.
13. Holtskog R, Sandvig K, Olsnes S. 1988. Characterization of a toxic lectin in Iscador, a mistletoe preparation with alleged cancerostatic properties. Oncology 45: 172-179.
14. Jung ML, Baudino S, Ribéreau-Gayon G, Beck JP. 1990. Characterization of cytotoxic proteins from mistletoe (Viscum album L.). Cancer Lett 51: 103-108.
15. Jurin M, Zarkovic N, Hrzenjak M, Ilic Z. 1993. Antitumorous and immunomodulatory effects of the Viscum album L. preparation Isorel. Oncology 50: 393-398.
16. Kiene H. 1989. Klinische Studien zur Misteltherapie karzinomatöser Erkrankungen. Therapeutikon 6: 347-353.
17. Kienle GS, Kiene H. 2007. Complementary cancer therapy: a systematic review of prospective clinical trials on anthroposophic mistletoe extracts. Eur J Med Res 12: 103-119.
18. Kleijnen J, Knipschild P. 1994. Mistletoe treatment for cancer: Review of controlled trials in humans. Phytomedicine 1:255-260.
19. Kovacs E. 2000. Serum levels of IL-12 and the production of IFN-gamma, IL-2 and IL-4 by peripheral blood mononuclear cells (PBMC) in cancer patients treated with Viscum album extract. Biomed Pharmacother 54: 305-310.
20. Kuttan G, Vasudevan DM, Kuttan R. 1990. Effect of a preparation from Viscum album on tumor development in vitro and in mice. J Ethnopharmacol 29: 35-41.
21. Leroi A, Leroi R. 1987. Carcinoma: Etiologia e Terapêutica. In A Imagem do Homem como Base da Arte Médica, Husemann F, Wolff O. Associação Beneficente Tobias e Associação Brasileira de Medicina Antroposófica: São Paulo; 794-825.
22. Moschèn R, Kemmler G, Schweigkofler H et al. 2001. Use of alternative/complementary therapy in breast cancer patients - a psychological perspective. Support Care Cancer 9: 267-274.
23. National Cancer Institute, Cancer Therapy Evaluation Program. Common Terminology Criteria for Adverse Events v3.0 (CTCAE). Publish Date December 12, 2003. Accessed March 18, 2004 at http://ctep.cancer.gov/reporting/ctc.html.
24. Pelletier M, Lavastre V, Savoie A et al. 2001. Modulation of interleukin-15-induced human neutrophil responses by the plant lectin Viscum album agglutinin-I. Clin Immunol 101:229-236.
25. Rentea R, Lyon E, Hunter R. 1981. Biologic properties of Iscador: a Viscum album preparation. I. Hyperplasia of the thymic cortex and accelerated regeneration of hematopoietic cells following x-irradiation. Lab Invest 44: 43-48.
26. Ribéreau-Gayon G, Jung ML, Baudino S, Sallé G, Beck JP. 1986. Effects of mistletoe (Viscum album L.) extracts on cultured tumor cell. Experientia 42: 594-599.
27. Romagnoli S, Fogolari F, Catalano M et al. 2003. NMR solution structure of viscotoxin C1 from Viscum album species Coloratum ohwi: toward a structure-function analysis of viscotoxins. Biochemistry 42: 12503-12510.
28. Siegle I, Fritz P, McClellan M, Gutzeit S, Mürdter TE. 2001. Combined cytotoxic action of Viscum album agglutinin-1 and anticancer agents against human A549 lung cancer cells. Anticancer Res 21 (4A): 2687-2691.
29. Stein GM, Berg PA. 2000. Adverse effects during therapy with mistletoe extracts. In Mistletoe, The Genus Viscum, Büssing A (ed.). Harwood Academic Publishers: Amsterdam; 195-208.
30. Stein GM, Edlund U, Pfüller U, Büssing A, Schietzel M. 1999a. Influence of polysaccharides from Viscum album L. on human lymphocytes, monocytes and granulocytes in vitro. Anticancer Res 19(5B): 3907-3914.
31. Stein GM, Schaller G, Pfüller U, Schietzel M, Büssing A. 1999b. Thionins from Viscum album L: influence of the viscotoxins on the activation of granulocytes. Anticancer Res 19(2A):1037-1042.